Literature DB >> 22449368

Current concepts of clinical management of multiple myeloma.

Sai Ravi Pingali1, Rami Y Haddad, Ayman Saad.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22449368     DOI: 10.1016/j.disamonth.2012.01.006

Source DB:  PubMed          Journal:  Dis Mon        ISSN: 0011-5029            Impact factor:   3.800


× No keyword cloud information.
  3 in total

1.  Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies.

Authors:  David Siegel; Thomas Martin; Ajay Nooka; R Donald Harvey; Ravi Vij; Ruben Niesvizky; Ashraf Z Badros; Sundar Jagannath; Leanne McCulloch; Kanya Rajangam; Sagar Lonial
Journal:  Haematologica       Date:  2013-08-09       Impact factor: 9.941

Review 2.  Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib.

Authors:  R Donald Harvey
Journal:  Clin Pharmacol       Date:  2014-05-08

Review 3.  Lenalidomide treatment for multiple myeloma: systematic review and meta-analysis of randomized controlled trials.

Authors:  Bo Yang; Rui-li Yu; Xiao-hua Chi; Xue-chun Lu
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.